Article
Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
Hematology/oncology and stem cell therapy - 1 Jan 2010
Banklau Chumphorn, Jindadamrongwech Sumalee, Sawangpanich Ruchchadol, Apibal Suntaree, Hongeng Suradej, Paisooksantivatana Karan, Pakakasama Samart
Abstract excerpt
BACKGROUND: Single nucleotide polymorphisms (SNPs) of deoxycytidine kinase (dCK) and cytidine deaminase (CDA) are known to alter their enzymatic activities, which affect the metabolism of cytarabine. Currently, treatment of childhood acute lymphoblastic leukemia (ALL) includes cytarabine, especially in high-risk patients. Therefore, we hypothesized that a genetic variation of dCK and CDA genes may influence the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
